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Pigmented villonodular synovitis is a disorder resulting in a villous, nodular, or villo-
nodular proliferation of the synovium, with pigmentation related to the presence of he-
mosiderin. These lesions are almost exclusively benign with rare reports of malignancy.
Pigmented villonodular synovitis can occur in a variety of joints and at any age but most
often occurs within the knee in the young adult. Pigmented villonodular synovitis is a rare
disease entity, and bilateral synchronous or metachronous involvement of a joint is even
more uncommon, with few reports previously described in the literature. We present a
case of pigmented villonodular synovitis involving both the right and left knee in the same
patient, with radiographic imaging, magnetic resonance imaging, photograph and video
intraoperative imaging, and pathologic correlation.
Copyright © 2015, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 62-year-old man, with a medical history of HLA-
B27epositive ankylosing spondylitis and asthma, initially
presented to his primary care provider in July 2001 with left
knee pain and a sensation that something was “popping out”
of the anteromedial aspect of the joint. There was no insta-
bility of the knee on physical examination. Radiographs of the
left knee were obtained, which demonstrated mild patellofe-
moral degenerative osteophyte formation with a small knee
joint effusion (Fig. 1). He was diagnosed with patellofemoral
osteoarthritis and subsequently made repeated visits to his
primary care provider and physical therapist over the next
several years because of persistent, nonremitting pain.ah).
blished by Elsevier Inc. u
ND license (http://creativIn September 2009, because of worsening pain, as well as
new symptoms of locking and a palpable, mobile lump along
the anteromedial joint line, amagnetic resonance imaging (MRI)
scanwas obtained.MRI revealed a joint effusion, patellofemoral
osteoarthritis, and a multilobulated lesion in continuity with
the synovium in the anteromedial patellofemoral joint space.
The lesion exhibited homogeneous enhancement and
“blooming” on gradient echo images (Fig. 1) and was suspicious
for pigmented villonodular synovitis (PVNS). He was referred to
the orthopedic surgery service at our institution, where he un-
derwent excision of the intra-articular lesion in January 2010.
Pathologic examination (Fig. 2) confirmed the diagnosis of
PVNS. After postsurgical rehabilitation, he has not experienced
recurrent left knee pain.nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1 eA 62-year-oldmanwith bilateral pigmented villonodular synovitis of the knee. Frontal (A) and lateral (B) radiographs
of the left knee demonstrate minimal patellofemoral osteophyte formation and small joint effusion. Sagittal T2 fat-
saturated (C) and sagittal (D) and axial (E) postcontrast T1-weighted magnetic resonance images of the left knee reveal a
lobulated, enhancing mass (arrows) in the anteromedial knee, which on excision was consistent with pigmented
villonodular synovitis.
Fig. 2 e A 62-year-old man with bilateral pigmented villonodular synovitis of the knee. (A) Low- and (B) high-power
photomicrographs demonstrate a sheet-like growth of mononuclear cells, primarily histiocyte-like, admixed with
multinucleated giant cells, some of which demonstrate a peripheral rim of hemosiderin, consistent with a diffuse-type
tenosynovial giant cell tumor.
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right knee to his primary care provider, which was diag-
nosed clinically as a ganglion cyst. In April 2012, he devel-
oped discomfort at the site of the lesion, and radiographs as
well as MRI scans were obtained in an effort to further
characterize (Fig. 3). The MRI demonstrated intra-articular
lesions similar to those detected within the contralateral
knee and most consistent with PVNS. The patient opted to
defer surgical intervention to avoid postoperative
rehabilitation.
Years later, the patient returned because of increasing
discomfort associated with the suspected PVNS lesion within
his right knee, at which time he was referred to the ortho-
pedic surgery service at our institution for definitive man-
agement. At this time, in November 2014, a follow-up MRI
was obtained. This demonstrated multiple intra-articular
lesions consistent with PVNS, similar in appearance to
those on the prior MRI scan acquired in April 2012, along with
multiple sites of cartilage loss in the medial and patellofe-
moral compartment. In January 2015, he underwentFig. 3 e A 62-year-old man with bilateral pigmented villonodul
radiographs of the right knee demonstrate a small joint effusio
gradient echo (E) images of the right knee demonstrate multiple
low signal intensity on the gradient echo sequence consistent w
in these areas of intra-articular PVNS.arthroscopic removal (Fig. 4) of the lesions along with syno-
vectomy and chondroplasty. Pathology was consistent with
PVNS (Fig. 5). He expressed resolution of his symptoms in the
early postoperative period.Discussion
PVNS was initially described in the tendon sheath by Chas-
saignac in 1852, with Simon later describing a nodular, intra-
articular form of the disease in 1865 [1,2]. As such, PVNS and
giant cell tumor of the tendon sheath are terms often used
interchangeably to describe these mostly benign pro-
liferations of the synovium affecting joints, tendon sheaths,
and bursae. Moser elucidated a diffuse form of the disease in
1909 [3]. In 1941, Jaffe consolidated the various forms of PVNS
and giant cell tumors of the tendon sheath, subclassifying the
disease based on diffuse or focal or nodular presentation and
intra-articular versus extra-articular location [4e6].ar synovitis (PVNS) of the knee. Frontal (A) and lateral (B)
n. Axial (C) and sagittal (D) T2 fat-saturated and sagittal
hypointense nodules (arrows) with focal areas of internal
ith susceptibility artifact related to hemosiderin deposition
Fig. 4 e A 62-year-old man with bilateral pigmented villonodular synovitis of the knee. Intraoperative photographs during
arthroscopy taken before (A) and after (B) resection of intra-articular mass (arrow). The supplementary video shows the
arthroscopic resection of the intra-articular mass from the right knee.
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tion system based on prognostic implications. The tumors are
divided into 2 categories dependent on location and behavior.
In specific terms, the diffuse-type giant cell tumor is defined
as a “destructive proliferation of synovial-like mononuclear
cells admixed with multinucleate giant cells, foam cells,
siderophages, and inflammatory cells” [7]. This form typically
involves a joint, but can involve extra-articular soft tissues,
and is characterized by an infiltrative, sheet-like growth
pattern. The localized type, which can be seen in the tendon
sheath, bursa, or joint space, demonstrates the same cell
types as the diffuse type but is typically smaller, more well
circumscribed, and less destructive than its diffuse-type
counterpart. Although both forms of the disease can recur
after surgical excision, rates are higher in the diffuse type [6,7].
Intra-articular PVNS is an uncommon disease with an
incidence of 1.8 cases per 1 million, typically presenting in the
fourth decade without a sex predilection. With respect to the
intra-articular form of the disease, the knee is the most
commonly involved joint, and the hip, elbow, and shoulderFig. 5 e A 62-year-old man with bilateral pigmented villonodul
photomicrographs demonstrate a sheet-like distribution of mon
hemosiderin deposition and collagenized stroma consistent wiare the next most common sites [5,6,8]. Absence of a palpable
lesion, which is less common with the diffuse intra-articular
form of disease, and the insidious onset of pain, swelling,
and motion restriction are the typical presenting symptoms.
Because of these relatively nonspecific symptoms, diagnosis
often requires months or years to establish [6,9].
Initial radiographs can be normal or reveal a joint effu-
sion, soft-tissue mass, and/or bony erosion. These extrinsic
erosions are well defined, often with rim sclerosis, and occur
on both sides of the joint. Erosions are likely due to contact
or mass effect on the adjacent bone and as such, more
commonly present in smaller, lower-capacity joints. Bone
mineralization and joint spaces are typically preserved [5,6].
Similar findings are seen with computed tomography (CT).
CT may also reveal synovial thickening, often exhibiting
increased attenuation owing to the presence of hemosiderin.
The intra-articular lesions are unlikely to be calcified,
allowing for differentiation from post-traumatic or degen-
erative intra-articular bodies or synovial osteochon-
dromatosis [6].ar synovitis of the knee. (A) Low- and (B) high-power
onuclear and multinucleated giant cells with peripheral
th diffuse-type tenosynovial giant cell tumor.
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aforementioned findings of erosions, joint effusion, syno-
vial thickening, and soft-tissue masses in greater frequency
and detail than radiographs or CT. Diffuse-type PVNS ap-
pears as a multinodular synovial thickening of low or in-
termediate signal intensity on all pulse sequences.
“Blooming” or accentuation of signal reduction on gradient
echo sequences due to magnetic susceptibility artifact from
hemosiderin is typical of PVNS [5,6,8]. Localized-type or
focal intra-articular PVNS manifests as a well-defined soft-
tissue mass with low to intermediate signal intensity on T1-
weighted images and heterogeneous appearance on T2-
weighted images. Blooming on gradient echo images is
commonly present but is less extensive than in the diffuse
form [6]. If intravenous gadolinium-based contrast is
administered, enhancement of the lesions is common,
more so in the diffuse than the localized form, and likely
because of the hypervascularity of the lesions. The hyper-
vascular nature of the lesions is also evident with angiog-
raphy or the blood flow and blood pool images of 3-phase
Tc-99m nuclear scintigraphy [6].
Polyarticular or multifocal disease, as in our case, is rare
and has been most frequently described in children, an age
group that otherwise rarely develops PVNS. There are only
scant previous reports of multifocal PVNS in adults. Many of
these reports predate the advent or widespread availability of
MRI. Of these cases, there are examples of bilateral disease at
presentation, as well as of metachronous lesions, as in our
case [8e16].
Surgical excision is the preferred management for both
localized and diffuse giant cell tumor of the joint, with suc-
cess being dependent on complete resection with clear
margins. In the setting of extensive diffuse disease, where
complete resection is unlikely, surgery is performed to
debulk before radiation or medical therapy, as well as to
provide symptomatic relief. Radiation therapy, both external
beam and radiosynoviorthesis, can be used in diffuse intra-
articular disease, preferably in conjunction with surgical
management. Medical therapy consists of immunomodu-
lating agents such as the tumor necrosis factor inhibitor
infliximab [6,8,9]. Widely varying recurrence rates have been
reported both for localized (0%-44%) and diffuse (8%-56%)
disease, with increased recurrence rates in cases in which
complete synovectomy could not be obtained, resulting in
residual disease at the resection margin. Positive outcomes
with surgery for localized disease and with surgery and
adjunct therapies have been described, highlighting the
value of making the diagnosis to allow for optimal and
timely management [5,6,8,9].
Although PVNS is a rare disease entity, and bilateral dis-
ease evenmore uncommon and only sparsely described in the
literature, it remains an important and treatable consider-
ation in a patient with chronic, progressive joint pain. Our
case of PVNS involving both the right and left knee in the same
patient demonstrates the radiographic and MRI appearance
of the disease, with photograph and video intra-operative
imaging and pathologic correlation.Supplementary data
Supplementary data associated with this article can be found
in the online version, at http://dx.doi.org/10.1016/j.radcr.2015.
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